Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, belongs to a class of medications called GLP-1 receptor agonists that were originally developed to treat type 2 diabetes. Clinical trials have demonstrated that semaglutide can reduce body weight by up to 22% when combined with lifestyle modifications. PlexusDx makes this medication accessible through compounded formulations at a fraction of retail pharmacy prices.
How Semaglutide Works for Weight Loss
Semaglutide functions by mimicking glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and blood sugar levels in the brain. When you take semaglutide, it slows gastric emptying—the rate at which food moves from your stomach into your small intestine—which creates prolonged feelings of fullness. This mechanism reduces hunger signals and helps lower overall calorie intake without requiring extreme dietary restriction.
The medication also influences regions of the brain responsible for reward and satiety, meaning food becomes less psychologically compelling. Patients typically report diminished cravings for high-calorie foods and improved portion control within the first two to four weeks of treatment. These neurological changes persist as long as you continue taking the medication, making it a sustained intervention rather than a temporary fix.
Clinical Evidence: Weight Loss Results and Timeline
The STEP trials, which studied semaglutide in non-diabetic adults with obesity, showed that participants achieved an average weight loss of 15% over 68 weeks at standard doses. In the highest-dose cohort, some patients lost more than 20% of their baseline body weight, equivalent to a 250-pound person losing 50 or more pounds. Weight loss typically becomes measurable within four to six weeks, with maximal results occurring between four and six months of consistent use.
Response varies based on individual metabolism, lifestyle adherence, and genetic factors influencing GLP-1 receptor sensitivity. PlexusDx offers the Precision Peptide Genetic Test, which analyzes your GLP1R rs6923761 variant and 48 other peptide-pathway markers to predict your personalized medication response. This testing helps optimize your treatment plan and allows your healthcare provider to select the most effective compound for your biology.
Compounded Semaglutide vs. Brand-Name Wegovy
Wegovy is the FDA-approved brand-name version of semaglutide marketed specifically for weight loss, while compounded semaglutide contains the identical active pharmaceutical ingredient manufactured and formulated by licensed 503A compounding pharmacies. Compounding allows medications to be customized in strength and delivery format, and compounded versions bypass the premium markup associated with branded pharmaceuticals. PlexusDx's compounded semaglutide injection starts at $149 per month, compared to Wegovy's retail price typically exceeding $900 monthly without insurance.
All medications dispensed through PlexusDx originate from licensed 503A compounding pharmacies that follow strict quality and sterility standards equivalent to FDA-regulated facilities. The active ingredient performs identically in your body regardless of whether it carries the Wegovy label or is compounded. Your dose may need to go up over time as your body builds tolerance, but your PlexusDx price remains flat—a transparent approach that eliminates surprise cost increases.
Accessibility and Cost-Effective Alternatives with PlexusDx
Insurance coverage for semaglutide weight loss medications remains inconsistent, with many plans requiring expensive prior authorization or denying coverage altogether. PlexusDx eliminates insurance prerequisites entirely—no membership fees, no insurance required, and service available across all 50 states. Monthly costs remain predictable: compounded semaglutide injection begins at $149, while oral semaglutide starts at $249, both HSA and FSA eligible to reduce out-of-pocket spending.
For patients seeking dual-mechanism therapy, PlexusDx offers GLP-Squared injection (combining semaglutide and tirzepatide compounds) starting at $249 monthly, or compounded tirzepatide injection alone at $249. The Microdose GLP-1 Protocol provides an entry point at $129 monthly for patients exploring lower-dose therapy. Adding the Precision Peptide Genetic Test after your first month ($99) refines your treatment approach by identifying which peptide pathways drive your weight gain, enabling truly personalized medication selection.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly will I see weight loss results with semaglutide?
Most patients notice measurable weight loss within four to six weeks of starting semaglutide, with more significant results appearing between four and six months. Individual timelines depend on your starting weight, lifestyle adherence, and genetic predisposition to GLP-1 receptor sensitivity—factors the PlexusDx Precision Peptide Genetic Test can clarify.
Is compounded semaglutide as effective as Wegovy?
Yes. Compounded semaglutide contains the identical active ingredient and produces identical weight loss outcomes as Wegovy when dosed appropriately. The difference lies in cost and accessibility—PlexusDx compounded semaglutide injection starts at $149 monthly versus Wegovy's typical $900+ retail price, with no insurance requirement.
What makes PlexusDx semaglutide more affordable?
PlexusDx sources medications from licensed 503A compounding pharmacies, which produce pharmaceutical-grade compounds without the marketing and distribution costs embedded in brand-name pricing. Flat monthly rates ensure your price never increases as your dose increases, and HSA/FSA eligibility further reduces your expenses.
Are there side effects with semaglutide, and how common are they?
Common side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose escalation. These typically subside within one to two weeks as your body adjusts. Serious side effects are rare but may include pancreatitis or thyroid concerns—reasons to maintain regular provider communication and report persistent symptoms promptly.
How does the Precision Peptide Genetic Test improve my weight loss outcomes?
The Precision Peptide Genetic Test analyzes 14 genetic pathways and 150+ insights, including your GLP1R rs6923761 variant, FTO rs9939609 fat mass gene, and GIPR rs1800437 glucose-dependent insulinotropic peptide receptor status. These markers predict how effectively your body responds to GLP-1 compounds versus tirzepatide, enabling your provider to select the medication most likely to work for your unique biology. At $99 after your first treatment month, this test transforms guesswork into precision medicine.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Back Pain a Side Effect of Ozempic?
Is Low Blood Pressure a Side Effect of Mounjaro?